Clinical trial
A Cross-sectional Study on the Positive Rate of Monoclonal Immunoglobulin (M Protein) in the Serum of Patients Seeking Medical Treatment in Tertiary Hospitals Based on a Highly Sensitive Serum M Protein Detection Method.
NCT06082284 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cross-sectional Study on the Positive Rate of Monoclonal Immunoglobulin (M Protein) in the Serum of Patients Seeking Medical Treatment in Tertiary Hospitals Based on a Highly Sensitive Serum M Protein Detection Method.
- Lead sponsor
- Zhujiang Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 10,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
m protein, multiple myeloma